$49.970
-0.110 (-0.22%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de TVTX por análisis de gráficos similares
Alphio's TVTX stock price prediction model matches the current Travere Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $50.57 (+1.21%). The 1-week path is $48.24 (-3.46%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Travere Therapeutics Inc?
Travere Therapeutics Inc is currently a hold. The stock is priced at $50.08, which is significantly below the analyst price targets ranging from $75 to $89, indicating potential upside. However, the RSI is at 31.377, suggesting the stock is oversold, and the forward P/E ratio is 39.84, indicating high valuation expectations. The main risk is the recent net loss of $34.79 million in Q2 2026, which is higher than the previous year's loss, highlighting ongoing financial challenges.
TVTX cerró en $49.97 el Monday, tras bajar -0.22%
Travere Therapeutics Inc (TVTX) last closed at $49.9700012, losing -0.22%. These facts feed the 1-day and 1-week TVTX price prediction above.
Factores de la previsión
Los factores de la previsión de Travere Therapeutics Inc (TVTX) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de TVTX, ordenadas por similitud.
Análisis de estacionalidad de TVTX
Historically the probability of a positive October return for TVTX is 100.00%. October offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de TVTX
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Oct 2026 | $26.19 | $28.89 | $34.13 | -42.19% |
| Nov 2026 | $18.78 | $21.70 | $29.21 | -56.57% |
| Dec 2026 | $17.95 | $22.30 | $24.24 | -55.36% |
En 2026, se proyecta que Travere Therapeutics Inc (TVTX) oscile entre $17.95 y $34.13.
Previsión mensual de Travere Therapeutics Inc para 2026
En Oct de 2026, se proyecta que Travere Therapeutics Inc promedie $28.89, con un mínimo de $26.19 y un máximo de $34.13.
En Nov de 2026, se proyecta que Travere Therapeutics Inc promedie $21.70, con un mínimo de $18.78 y un máximo de $29.21.
En Dec de 2026, se proyecta que Travere Therapeutics Inc promedie $22.30, con un mínimo de $17.95 y un máximo de $24.24.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.